Results 31 to 40 of about 1,374 (169)

Triclabendazole sulfoxide causes stage-dependent embryolethality in zebrafish and mouse in vitro.

open access: yesPLoS ONE, 2015
BackgroundFascioliasis and paragonimiasis are widespread foodborne trematode diseases, affecting millions of people in more than 75 countries. The treatment of choice for these parasitic diseases is based on triclabendazole, a benzimidazole derivative ...
Nuria Boix   +6 more
doaj   +1 more source

Hepatic fascioliasis: case report and review Fasciolíase hepática. Relato de um caso e revisão da literatura

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 1996
A well documented case of hepatic fascioliasis (HF), successfully treated with triclabendazole, is reported. Predominant clinical manifestations were fever, marked eosinophilia and abdominal pain.
Salha Abdul-Hadi   +4 more
doaj   +1 more source

Triclabendazole-resistant Fasciola hepatica: β-tubulin and response to in vitro treatment with triclabendazole [PDF]

open access: yesParasitology, 2002
Resistance in Fasciola hepatica to triclabendazole (‘Fasinex’) has emerged in several countries. Benzimidazole resistance in parasitic nematodes has been linked to a single amino acid substitution (phenylalanine to tyrosine) at position 200 on the β-tubulin molecule.
Hoey, Elizabeth   +3 more
  +11 more sources

Etude pharmacocinétique comparée du triclabendazole chez le mouton et le dromadaire

open access: yesRevue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux, 1991
Les auteurs décrivent la pharmacocinétique comparée du triclabendazole chez trois dromadaires et quatre moutons qui ont reçu une dose orale unique de 10 mg de triclabendazole par kg de poids vif. Les concentrations plasmatiques de triclabendazole et des
Mohamed Oukessou   +3 more
doaj   +1 more source

Review on bioanalytical approaches for analysis triclabendazole as veterinary residue in different matrices [PDF]

open access: yesRecords of Pharmaceutical & Biomedical Sciences, 2023
Anthelmintics drugs are used to treat infectious diseases in the intestinal tract of animals caused by parasitic worms. These drugs are important in the livestock industry for controlling coccidiosis, a parasitic disease that can have significant ...
Aya Attia   +4 more
doaj   +1 more source

Study of subchronic oral toxicity of Altric-Extra drug in laboratory animals

open access: yesРоссийский паразитологический журнал, 2023
The purpose of the research is to determine main toxicological parameters in repeated intragastric administration of Altric-Extra for veterinary use to laboratory outbred rats.Materials and methods.
V. V. Golovin   +3 more
doaj   +1 more source

Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.

open access: yesPLoS Neglected Tropical Diseases, 2016
Triclabendazole is reported to be highly effective in treatment of human fascioliasis. We present 7 of 19 selected cases of human fascioliasis referred to our center in the Cusco region of Peru that failed to respond to triclabendazole. These were mostly
Miguel M Cabada   +5 more
doaj   +1 more source

Hepatic Fascioliasis Complicated by Multisite Venous Thromboembolism: A Rare Association and Implications for Parasite-Associated Coagulopathy. [PDF]

open access: yesClin Case Rep
ABSTRACT Hepatic fascioliasis is a trematode flatworm infection caused by Fasciola hepatica or Fasciola gigantica. Its association with venous thrombosis is exceedingly rare and can lead to significant morbidity when complicated by such conditions. Here, we report a rare case of hepatic fascioliasis complicated by multisite venous thromboembolism (VTE),
Lema GD   +8 more
europepmc   +2 more sources

High prevalence of fasciolosis and evaluation of the efficacy of anthelmintics against Fasciola hepatica in buffaloes in Guangxi, China

open access: yesInternational Journal for Parasitology: Parasites and Wildlife, 2019
Fasciola hepatica is a common parasite of grazing livestock in Guangxi Zhuang Autonomous Region in China, but its prevalence has not been studied. While triclabendazole is commonly used to treat F. hepatica infection in China, oxyclozanide has never been
Ji-Li Zhang   +5 more
doaj   +1 more source

Triclabendazole in the treatment of human fascioliasis: a review [PDF]

open access: yesTransactions of The Royal Society of Tropical Medicine and Hygiene, 2019
AbstractFascioliasis occurs on all inhabited continents. It is caused by Fasciola hepatica and Fasciola gigantica, trematode parasites with complex life cycles, and primarily affects domestic livestock. Humans become infected after ingestion of contaminated food (typically wild aquatic vegetables) or water.
Gandhi, Preetam   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy